Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.84 USD | +3.96% | -21.17% | -89.85% |
05-08 | Aptevo Therapeutics Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
04-11 | US Equity Markets Close Mixed After March Producer Price Inflation Data | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-89.85% | 1.3M | |
+7.75% | 113B | |
+10.62% | 106B | |
+0.41% | 22.27B | |
-12.08% | 22.22B | |
-5.99% | 19.43B | |
-37.36% | 17.87B | |
-4.86% | 17.24B | |
+6.60% | 14.29B | |
+35.41% | 12.52B |
- Stock Market
- Equities
- APVO Stock
- News Aptevo Therapeutics Inc.
- Aptevo Therapeutics Says Leukemia Combination Therapy Showed Clinical Benefit in Early Stage Study